Ascenta Capital
Overview
Ascenta Capital invests in biotechs.
Investment Focus
- Companies developing multiple medicines from a single core technology
- Early clinical-stage biotech companies with diversified pipelines
Portfolio Companies
Get the full list of 54,000+ investors
Ascenta Capital and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Ascenta Capital
What sectors does Ascenta Capital invest in?
Ascenta Capital invests in Healthcare and Biotechnology, and is based in United States. Ascenta Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Ascenta Capital invest at?
Ascenta Capital backs companies at Early Stage and Growth, writing cheques of 15M - 30M.
Which regions does Ascenta Capital invest in?
Ascenta Capital invests across United States.
Who are the partners at Ascenta Capital?
Team members listed for Ascenta Capital include Evan RACHLIN (Co-Founder and Managing Partner) and David Shields (Chief Financial Officer).
What companies has Ascenta Capital invested in?
Ascenta Capital's portfolio includes Odyssey Therapeutics, Iambic Therapeutics, ADARx Pharmaceuticals, Cardurion Pharma, OrsoBio and Alpha9 Oncology.
How do I contact Ascenta Capital?
Ascenta Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
